α-Adrenoceptor mechanisms of thermoregulation during cold challenge in humans

Steven Mark Frank, Nader El-Gamal, Srinivasa Naga Raja, Peter K. Wu

Research output: Contribution to journalArticle

Abstract

1. Previous studies on the thermoregulatory effects of α-adrenoceptor antagonists have been performed primarily in animals and the findings have been inconsistent. There is evidence for thermoregulatory impairment by α-adrenergic antagonists in humans not exposed to cold, but the effects of α-adrenergic blockade during cold challenge have not been investigated. 2. Fourteen healthy human volunteers (seven elderly, aged 55-68 years and seven young, aged 19-27 years) were studied on three separate days and received three randomly assigned treatments: (i) control (no drug), (ii) low-dose phentolamine, and (iii) high-dose phentolamine. On each day cold intravenous saline (4°C) was given until both vasoconstriction and shivering were triggered or a maximum fluid volume (40 ml/kg) was delivered. Core temperature, peripheral vasoconstriction and metabolic heat production were measured. 3. The α-adrenoceptor antagonist caused a dose-dependent inhibition of vasoconstriction in the elderly but did not impair vasoconstriction in the young subjects at the doses that were given. Shivering and metabolic heat production were unaffected by α-adrenergic blockade in the elderly or in the young. 4. These findings illustrate the selective inhibition of vasoconstriction (but not shivering) by α-adrenoceptor antagonism in elderly individuals. Compared with the young, the elderly are more sensitive to the effects of α-antagonists, perhaps due to downregulation of the α-adrenoceptor. These Endings lead us to conclude that thermoregulatory vasoconstriction is α-adrenergically mediated, and this response is attenuated by α-adrenoceptor blockade in elderly humans.

Original languageEnglish (US)
Pages (from-to)627-631
Number of pages5
JournalClinical Science
Volume91
Issue number5
StatePublished - 1996

Fingerprint

Body Temperature Regulation
Vasoconstriction
Adrenergic Receptors
Shivering
Thermogenesis
Phentolamine
Adrenergic Agents
Adrenergic Antagonists
Drug and Narcotic Control
Healthy Volunteers
Down-Regulation
Temperature

Keywords

  • Alpha-adrenoceptor
  • Antagonist
  • Hypothermia
  • Metabolism
  • Phentolamine
  • Thermoregulation
  • Vasoconstriction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

α-Adrenoceptor mechanisms of thermoregulation during cold challenge in humans. / Frank, Steven Mark; El-Gamal, Nader; Raja, Srinivasa Naga; Wu, Peter K.

In: Clinical Science, Vol. 91, No. 5, 1996, p. 627-631.

Research output: Contribution to journalArticle

@article{881d304c73554bcfa1792d3fbd2b074d,
title = "α-Adrenoceptor mechanisms of thermoregulation during cold challenge in humans",
abstract = "1. Previous studies on the thermoregulatory effects of α-adrenoceptor antagonists have been performed primarily in animals and the findings have been inconsistent. There is evidence for thermoregulatory impairment by α-adrenergic antagonists in humans not exposed to cold, but the effects of α-adrenergic blockade during cold challenge have not been investigated. 2. Fourteen healthy human volunteers (seven elderly, aged 55-68 years and seven young, aged 19-27 years) were studied on three separate days and received three randomly assigned treatments: (i) control (no drug), (ii) low-dose phentolamine, and (iii) high-dose phentolamine. On each day cold intravenous saline (4°C) was given until both vasoconstriction and shivering were triggered or a maximum fluid volume (40 ml/kg) was delivered. Core temperature, peripheral vasoconstriction and metabolic heat production were measured. 3. The α-adrenoceptor antagonist caused a dose-dependent inhibition of vasoconstriction in the elderly but did not impair vasoconstriction in the young subjects at the doses that were given. Shivering and metabolic heat production were unaffected by α-adrenergic blockade in the elderly or in the young. 4. These findings illustrate the selective inhibition of vasoconstriction (but not shivering) by α-adrenoceptor antagonism in elderly individuals. Compared with the young, the elderly are more sensitive to the effects of α-antagonists, perhaps due to downregulation of the α-adrenoceptor. These Endings lead us to conclude that thermoregulatory vasoconstriction is α-adrenergically mediated, and this response is attenuated by α-adrenoceptor blockade in elderly humans.",
keywords = "Alpha-adrenoceptor, Antagonist, Hypothermia, Metabolism, Phentolamine, Thermoregulation, Vasoconstriction",
author = "Frank, {Steven Mark} and Nader El-Gamal and Raja, {Srinivasa Naga} and Wu, {Peter K.}",
year = "1996",
language = "English (US)",
volume = "91",
pages = "627--631",
journal = "Clinical Science",
issn = "0143-5221",
publisher = "Portland Press Ltd.",
number = "5",

}

TY - JOUR

T1 - α-Adrenoceptor mechanisms of thermoregulation during cold challenge in humans

AU - Frank, Steven Mark

AU - El-Gamal, Nader

AU - Raja, Srinivasa Naga

AU - Wu, Peter K.

PY - 1996

Y1 - 1996

N2 - 1. Previous studies on the thermoregulatory effects of α-adrenoceptor antagonists have been performed primarily in animals and the findings have been inconsistent. There is evidence for thermoregulatory impairment by α-adrenergic antagonists in humans not exposed to cold, but the effects of α-adrenergic blockade during cold challenge have not been investigated. 2. Fourteen healthy human volunteers (seven elderly, aged 55-68 years and seven young, aged 19-27 years) were studied on three separate days and received three randomly assigned treatments: (i) control (no drug), (ii) low-dose phentolamine, and (iii) high-dose phentolamine. On each day cold intravenous saline (4°C) was given until both vasoconstriction and shivering were triggered or a maximum fluid volume (40 ml/kg) was delivered. Core temperature, peripheral vasoconstriction and metabolic heat production were measured. 3. The α-adrenoceptor antagonist caused a dose-dependent inhibition of vasoconstriction in the elderly but did not impair vasoconstriction in the young subjects at the doses that were given. Shivering and metabolic heat production were unaffected by α-adrenergic blockade in the elderly or in the young. 4. These findings illustrate the selective inhibition of vasoconstriction (but not shivering) by α-adrenoceptor antagonism in elderly individuals. Compared with the young, the elderly are more sensitive to the effects of α-antagonists, perhaps due to downregulation of the α-adrenoceptor. These Endings lead us to conclude that thermoregulatory vasoconstriction is α-adrenergically mediated, and this response is attenuated by α-adrenoceptor blockade in elderly humans.

AB - 1. Previous studies on the thermoregulatory effects of α-adrenoceptor antagonists have been performed primarily in animals and the findings have been inconsistent. There is evidence for thermoregulatory impairment by α-adrenergic antagonists in humans not exposed to cold, but the effects of α-adrenergic blockade during cold challenge have not been investigated. 2. Fourteen healthy human volunteers (seven elderly, aged 55-68 years and seven young, aged 19-27 years) were studied on three separate days and received three randomly assigned treatments: (i) control (no drug), (ii) low-dose phentolamine, and (iii) high-dose phentolamine. On each day cold intravenous saline (4°C) was given until both vasoconstriction and shivering were triggered or a maximum fluid volume (40 ml/kg) was delivered. Core temperature, peripheral vasoconstriction and metabolic heat production were measured. 3. The α-adrenoceptor antagonist caused a dose-dependent inhibition of vasoconstriction in the elderly but did not impair vasoconstriction in the young subjects at the doses that were given. Shivering and metabolic heat production were unaffected by α-adrenergic blockade in the elderly or in the young. 4. These findings illustrate the selective inhibition of vasoconstriction (but not shivering) by α-adrenoceptor antagonism in elderly individuals. Compared with the young, the elderly are more sensitive to the effects of α-antagonists, perhaps due to downregulation of the α-adrenoceptor. These Endings lead us to conclude that thermoregulatory vasoconstriction is α-adrenergically mediated, and this response is attenuated by α-adrenoceptor blockade in elderly humans.

KW - Alpha-adrenoceptor

KW - Antagonist

KW - Hypothermia

KW - Metabolism

KW - Phentolamine

KW - Thermoregulation

KW - Vasoconstriction

UR - http://www.scopus.com/inward/record.url?scp=0029997185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029997185&partnerID=8YFLogxK

M3 - Article

C2 - 8942402

AN - SCOPUS:0029997185

VL - 91

SP - 627

EP - 631

JO - Clinical Science

JF - Clinical Science

SN - 0143-5221

IS - 5

ER -